 Sorrento Therapeutics NASDAQ: SRNE shares are trading higher on Wednesday after the company announced it has received CLIA Licensure from the State of California that permits testing of clinical samples. Sorrento Therapeutics is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmuneinflammation diseases. 